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Abstract
Background—Racial differences in adherence to prescribed medication regimens have been
reported among the elderly. It remains unclear, however, whether these differences persist after
controlling for confounding variables.
Objective—The objective of this study was to determine whether racial differences in
medication adherence between African American and white seniors persist after adjusting for
demographic characteristics, health literacy, depression, and social support. We hypothesized that
differences in adherence between the 2 races would be eliminated after adjusting for confounding
variables.
Methods—A survey on medication adherence was conducted using face-to-face interviews with
Medicare recipients ≥65 years of age living in Chicago. Participants had to have good hearing and
vision and be able to speak English to enable them to respond to questions in the survey and sign
the informed-consent form. Medication adherence measures included questions about: (1) running
out of medications before refilling the prescriptions; (2) following physician instructions on how
to take medications; and (3) forgetting to take medications. Individual crude odds ratios (CORs)
were calculated for the association between race and medication adherence. Adjusted odds ratios
(AORs) were calculated using the following covariates in multivariate logistic regression analyses:
race; age; sex; living with a spouse, partner, or significant other; income; Medicaid benefits;
prescription drug coverage; having a primary care physician; history of hypertension or diabetes;
health status; health literacy; depression; and social support.
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Results—Six hundred thirty-three eligible cases were identified. Of the 489 patients who
responded to the survey, 450 (266 African American [59%; mean age, 78.2 years] and 184 white
[41%; mean age, 76.8 years]; predominantly women) were included in the sample. The overall
response rate for the survey was 77.3%. African Americans were more likely than whites to report
running out of medications before refilling them (COR = 3.01; 95% CI, 1.72–5.28) and not always
following physician instructions on how to take medications (COR = 2.64; 95% CI, 1.50–4.64).
However, no significant difference between the races was observed in forgetting to take
medications (COR = 0.90; 95% CI, 0.61–1.31). In adjusted analyses, race was no longer
associated with low adherence due to refilling (AOR = 1.60; 95% CI, 0.74–3.42). However, race
remained associated with not following physician instructions on how to take medications after
adjusting for confounding variables (AOR = 2.49; 95% CI, 1.07–5.80).
Conclusion—Elderly African Americans reported that they followed physician instructions on
how to take medications less frequently than did elderly whites, even after adjusting for
differences in demographic characteristics, health literacy, depression, and social support.
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INTRODUCTION
Low adherence to prescribed medication regimens is common and associated with increases
in morbidity, mortality, and health care costs.1-6 This is a particularly important concern
among the elderly, many of whom have multiple chronic conditions that require complex
medication regimens.4,7 In addition, older individuals may have greater difficulty in
following prescription instructions due to age-related cognitive changes, declining memory,
and impaired vision.8,9 Complex medical therapy, coupled with limited support in
addressing these barriers to accessing and taking medications, increases the risks of low
adherence and consequent hospitalization.4,10
Among the elderly, adherence to prescribed medication regimens has been reported to be
lower among African Americans than among whites.11-19 A cross-sectional survey12
reported that African Americans were more likely to report cost-related low adherence than
were whites (35.1% vs 26.7%). In another investigation,11 elderly African Americans were
more likely to have cost-related low adherence than were whites even after adjusting for
demographic characteristics, including income and prescription drug coverage.
Factors other than cost also may affect medication adherence and potentially contribute to
racial differences. For example, some studies8,20 suggest that low health literacy is
associated with low medication adherence, including refill adherence. One study21
suggested that health literacy may mediate the relationship between African American race
and adherence to therapy for HIV. Depression, which is prevalent among the elderly, has
been associated with low medication adherence, especially for those with chronic
diseases.22-26 Milder symptoms of depression without a formal diagnosis of major
depression may also be associated with low adherence in self-management of chronic
diseases such as diabetes.27 African Americans may be less likely to be diagnosed and
treated for depression in the primary care setting, contributing to racial differences in
medication adherence.28 In contrast, strong social support may improve adherence and
potentially attenuate the effect of health literacy and depression on medication
adherence.9,29,30 Varied levels of social support could affect racial differences, where older
African Americans may utilize informal social networks more often than whites.31,32 To
further assess predictors of medication adherence and differences by race, these factors
should be concomitantly evaluated and included in adherence models.
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It remains unclear whether racial differences in medication adherence behaviors exist after
adjustment for these important confounders. Racial differences in medication adherence
warrant further study because poor adherence may directly contribute to differences in
chronic disease management, cardiovascular events, and mortality.33,34 In the Veterans
Affairs health care system, racial differences exist for medication adherence despite equal
access and cost; more detailed individual data are needed to explore the causes of these
differences.35
In the present study, cross-sectional data were obtained through face-to-face interviews with
Medicare beneficiaries ≥65 years of age living in Chicago, Illinois, to determine whether
racial differences in medication adherence between African Americans and whites persist
after adjusting for demographic characteristics, health literacy, depression, and social
support. We hypothesized that differences in adherence between African American and
white seniors would be eliminated after this adjustment.
METHODS
Data Collection
Medicare recipients ≥65 years of age completed face-to-face interviews in their homes or at
their participating medical center between March 2003 and February 2004 (before
implementation of Medicare Part D). These patients participated in a study to explore the
relationship between health literacy, health status, and health service utilization.29
Participants with ≥1 out-patient clinic visit at the Mercy Hospital and Medical Center
(MHMC) or the Mercy Family Health Center, both located in Chicago, within the previous 4
years (1999–2003) were recruited. Institutional review boards at the University of Illinois at
Chicago, MHMC, and the University of North Carolina at Chapel Hill approved this study.
Potential respondents were screened by telephone for eligibility and willingness to
participate. Participants had to be currently living in Illinois, have good vision (determined
by vision questions during telephone screening and ability to see well enough during signing
of the consent form) and good hearing (determined by responses to the screener without the
use of a text telephone), and be able to conduct the interview in English. Participants were
screened for cognitive impairment by requesting individuals to identify the state, year, and
day of the week (minimum 2 out of 3 correct answers required for participation). In addition,
the Mini-Mental State Examination (MMSE)36 was administered. The MMSE was included
in our models and health literacy was left in the model without the MMSE due to
colinearity.
After training at the Survey Research Laboratory at the University of Illinois at Chicago,
interviews were conducted with eligible participants at a location chosen by the participant
(eg, home, clinic) using a computer-assisted interviewing system. The interview assessed the
respondent’s sociodemographic characteristics, health literacy, social support, mental health
status, medical comorbidities, and medication adherence.
Measurement of Outcome Variables
Medication adherence was assessed using questions based on the Hill-Bone Compliance to
High Blood Pressure Therapy Scale (medication-taking behavior subscale) and
recommended nonjudgmental interview approaches.37-39 Previous use of the Hill-Bone
compliance scale included African American37 and white40 populations. One study40 of
community-dwelling, elderly patients with hypertension found good reliability of the 9-item
medication compliance survey (Cronbach α = 0.68). The 3 items selected reflect how
frequently patients followed specific behaviors related to overall medication adherence,
without reference to specific types of medications. The questions included:
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1. Refilling Medication: “How often do you run out of your medications before you
refill them?” Adherence was defined as “none of the time.”
2. Following Instructions: “How often do you follow the physician’s instructions on
how to take your medications?” Adherence was defined as “all of the time.”
3. Forgetting Medication: “How often have you forgotten to take your medicine?”
Adherence was defined as “none of the time.”
Possible responses were “all of the time,” “most of the time,” “some of the time,” “a little of
the time,” or “none of the time.” Cutoff levels to define adherence were based on skewed
distributions of item results.
Measurement of Other Variables
Health literacy was measured using the Short Test of Functional Health Literacy in Adults.41
Test scores were classified into 2 health literacy categories: inadequate (0–22, subject is
unable to read and interpret health texts or has difficulty doing so) and adequate (23–36,
subject can read and interpret most health texts). Depression was measured using the 15-
item short form of the Geriatric Depression Scale (Cronbach α = 0.806)42,43; scores were
classified into the following categories: normal (0–4), mild depression (5–9), and moderate
to severe depression (10–15). Social support was measured through the perceived social
support scale developed in the Medical Outcomes Study,44 which assesses emotional,
informational, tangible, positive social interaction, and affectionate support (Cronbach α =
0.869). We also asked whether participants lived with someone (ie, a spouse, partner, or
significant other).
Participants were asked about their annual income level (ie, including income from all
sources and from all members of the household). Participants were asked whether they
received Medicaid benefits and whether they had prescription drug coverage through either
their health insurance or a special government program. To evaluate access to a primary care
physician, participants were asked whether they had one main person they thought of as
their personal doctor or health care provider. To determine whether participants had a
history of hypertension or diabetes, they were asked whether they had ever been told by a
doctor, nurse, or other health care professional that they had one of these conditions. An
item self-rated on a 5-point Likert scale (excellent, very good, good, fair, or poor; coded 1–
5, respectively) was used to assess health status. This single-item assessment of global
health status is a valid, reliable, and useful measure of an individual’s well-being.45,46 A
similar item can be found in the Short Form Health Survey as well as the National Health
Interview Survey, National Health and Nutrition Examination Survey, and Behavioral Risk
Factor Surveillance System national instruments.46,47 Reponses to this item are highly
correlated with many health outcomes and mortality.46 Also included in the analysis were
the respondent’s age and sex.
Statistical Analysis
To assess differences in characteristics between the African American and white
participants, standard 2-tailed t tests were performed for continuous variables and χ2 tests
for categorical variables. Results were examined to determine whether racial differences
existed in medication adherence outcomes. Individual crude odds ratios (CORs) were
calculated for the association between race (African American vs white) and medication
adherence (refilling medications, following physician instructions, and forgetting
medications). Multivariate logistic regression analyses were used to calculate adjusted odds
ratios (AORs) for the 3 adherence outcomes, using the following covariates: race; age; sex;
living with a spouse, partner, or significant other; income; Medicaid benefits; prescription
drug coverage; having a primary care physician; history of hypertension or diabetes; health
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status; health literacy; depression; and social support. According to the framework
developed by Murray et al,9 these covariates represented important personal characteristics
that may explain medication adherence. All ORs were reported with 95% CIs, with
significance defined as P < 0.05. All analyses were conducted using SPSS for Windows
version 16.0 (SPSS Inc., Chicago, Illinois).
RESULTS
Description of the Study Sample
Six hundred thirty-three eligible cases were identified; 489 patients responded to the survey
(overall response rate, 77.3%). The sample included 450 participants 66 to 103 years of age
(266 [59%] African American and 184 [41%] white; self-identified) (Table I); the ethnic
groups for the remaining 39 patients were small in number and diverse. The 2 primary racial
groups were similar in terms of sex: 78.2% of African American participants and 79.3% of
white participants were women (P = 0.77). In addition, a majority of both racial groups
reported having prescription drug coverage (72.5% of African Americans vs 73.8% of
whites; P = 0.77). However, compared with white participants, African American
participants were older (mean age, 78.2 vs 76.8 years; P = 0.026), had less income (P <
0.001), and had received greater Medicaid benefits (53.6% vs 21.3%; P < 0.001). Fewer
African Americans reported living with a spouse, partner, or significant other (19.2% vs
28.3%; P = 0.024) or having a primary care physician (84.2% vs 96.2%; P < 0.001). More
African Americans reported having a history of hypertension (70.7% vs 57.1%; P = 0.003)
or diabetes (26.3% vs 14.7%; P = 0.003), as well as worse health status, lower health
literacy, worse depression scores, and less social support than did white participants (all, P <
0.001).
Unadjusted Medication Adherence Outcomes
Participants in the 2 racial groups reported significantly different responses to 2 of the 3
medication adherence questions (Table II). Whites were more likely than African Americans
to report never running out of medications before refilling them (90.2% vs 75.3%; COR =
3.01; 95% CI, 1.72–5.28) and more likely to follow physician instructions on how to take
medications (90.1% vs 77.6%; COR = 2.64; 95% CI, 1.50–4.64). However, no significant
between-race difference was observed in participants forgetting to take their medications
(47.8% of whites vs 50.6% of African Americans; COR = 0.90; 95% CI, 0.61–1.31).
Multivariate Analyses
Multivariate logistic regression was performed to evaluate the 3 medication adherence items
(running out of medications, not following physician instructions, and forgetting
medications) (Table III). After controlling for variables (age; sex; living with a spouse,
partner, or significant other; income; Medicaid benefits; prescription drug coverage; having
a primary care physician; history of hypertension or diabetes; health status; health literacy;
depression; and social support), race was no longer associated with low adherence due to
refilling (AOR = 1.60; 95% CI, 0.74–3.42). In addition, none of the covariates was
statistically significant at the P < 0.05 level. However, African Americans were more likely
than whites to not always follow physician instructions on how to take medications (AOR =
2.49; 95% CI, 1.07–5.80) after controlling for the same variables. In contrast, a history of
hypertension (AOR = 0.38; 95% CI, 0.20–0.71) and social support (AOR = 0.51; 95% CI,
0.35–0.76) were associated with following physician instructions on how to take
medications. In the multivariate model of forgetting medications, income (2003–2004 US $)
of $20,000 to $24,999 (AOR = 0.45; 95% CI, 0.22–0.93), $10,000 to $14,999 (AOR = 0.39;
95% CI, 0.18–0.84), and <$10,000 (AOR = 0.34; 95% CI, 0.14–0.83), and social support
(AOR = 0.60; 95% CI, 0.44–0.81) were significant.
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In this sample of Medicare enrollees, a significant difference in self-reported medication
adherence—following physician instructions on how to take medications—was found
between African American and white participants. This discrepancy persisted after adjusting
for confounding variables. Although African American participants had significantly lower
health literacy, depression scores, and social support than did whites, race remained an
important factor in the multivariate model.
The difference in following physician instructions on how to take medications is consistent
with other studies that reported lower rates of medication adherence among African
American populations than among white populations.10-18 This form of medication
adherence represents intentional adherence, which typically involves a decision-making
process (weighing the costs and benefits of taking medication).48,49 This may also reflect
differences in knowledge, attitudes, or lay health beliefs that influence medication decisions,
resulting in skipping or altering doses. In one study of low-income persons with diabetes,50
African Americans were found to be more concerned about medication harmfulness than
were whites, independent of income, medication cost, and health literacy. This concern for
harm was associated with medication underuse and worse blood pressure control. African
Americans may also express greater concern for medication adverse effects and dependency
than their white counterparts, as well as greater reluctance to adding medication to their
regimens.51 Differences in patient–provider relationships (eg, patient–physician
communication concerning prescriptions, trust) may further contribute to the discrepancy in
adherence.52,53 Together, these concerns may affect individual decisions pertaining to
following physician instructions on how to take medications and potentially explain racial
differences in intentional adherence. In contrast, no significant differences in running out of
medications before refilling or forgetting to take medications were observed between
African American and white participants in the full, adjusted models. It is possible that these
2 types of medication adherence rely less on individual attitudes and beliefs.49
Social support was associated with both following physician instructions on how to take
medications and forgetting to take medications. Other studies have found similar
associations between perceived social support and adherence.4,54,55 The involvement of
others (eg, family members, neighbors) in providing knowledge and reminders may help to
overcome barriers to long-term medication adherence, especially when support efforts are
tailored to an individual’s specific needs.56 This is particularly relevant for the elderly who
live alone and have cognitive impairment or disability. Greater use of informal social
networks by African American seniors may improve medication adherence, but likely would
not eliminate the impact of race on adherence.
No significant differences in forgetting to take medications were found between African
American and white seniors. This form of unintentional nonadherence is common; ~50% of
the sample reported forgetting to take their medications. Other studies have also found
relatively high rates of various forms of low medication adherence among seniors. For
example, in a 2003 national survey of Medicare beneficiaries aged ≥65 years, 40% of the
sample reported some form of medication nonadherence during the past year.57 Low
adherence rates were reported more frequently for those with complex chronic conditions,
low income, and no prescription drug coverage (range, 48%–52%).
Previous research suggests that forgetfulness is a common cause of poor medication
adherence; this includes retrospective memory failure (forgetting what they have been told
about medications and whether they took their medications) and prospective memory failure
(forgetting to take their medications).9,58 Because of the high degree of forgetfulness
Gerber et al. Page 6













described by seniors overall (~50% of the sample), interventions are needed to specifically
address this problem. Examples of interventions include cueing, chaining (associating new
and established behaviors), use of social support or ancillary clinical services (eg, family
members, nurses, pharmacists), and electronic monitoring devices.1 Providers can help by
simplifying seniors’ complex medical regimens (eg, using once-daily dosing when possible)
and discontinuing unnecessary medications.
The major strength of this study is the inclusion of individualized assessments of health
literacy, depression, and social support among a cohort of Medicare enrollees who resided in
similar neighborhoods and were treated at the same medical facility. Thus, our results were
not confounded by geographic or organizational variations that may affect health care
delivery and patient adherence. However, a number of limitations must be acknowledged.
First, we utilized only self-reported adherence questions as outcomes. Other detailed surveys
that evaluate cost-related low adherence or alternative measures of adherence (eg, pill
counts, medication event monitoring systems) may improve adherence assessments. Second,
participants may have overestimated their levels of adherence to provide more desirable
responses during interviews. Third, participants indicated their overall adherence to
medication regimens, although the number, type, and complexity of the medications
prescribed likely vary widely. In this sample, adjustments for comorbid conditions (ie,
hypertension and diabetes) and health status did not significantly alter our results.
Adjustments were not made for other chronic conditions (eg, congestive heart failure,
coronary artery disease, chronic obstructive pulmonary disease) or disease prognosis.
Fourth, although cost-related nonadherence is a well-recognized problem, we were unable to
adjust for cost of medication. Fifth, the study sample came from an inner-city neighborhood
of a metropolitan area, which may have limited the generalizability of the findings. Finally,
the cross-sectional design precluded the determination of causality.
The finding of racial differences in medication adherence has important implications
because lower adherence can contribute to significant racial disparities in chronic disease
outcomes. The objective of reducing health disparities requires further investigation in
underlying differences that explain medication-related behaviors. We need better policies
and well-designed interventions to help those individuals who are most vulnerable—
minority seniors with low income levels and poor social support. Health care providers
should adopt a culturally sensitive, patient-centered approach to identifying and addressing
barriers to adherence. Improvements made in medication adherence may translate into better
management of chronic diseases and reduced disparities in cardiovascular and other diseases
that rely on complex medical therapy.
CONCLUSIONS
Racial differences exist in how seniors report taking medications. More African Americans
than whites reported not following their physician’s instructions on how to take medications.
The racial differences persisted after adjusting for demographic characteristics, including
income, prescription drug coverage, health literacy, depression, and social support.
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Table I
Characteristics of the study sample (N = 450). Data are % unless otherwise indicated.
Characteristic African American (n = 266) White (n = 184) P
Age, mean (SD) 78.2 (7.25) 76.8 (6.05) 0.026
Sex, male 21.8 20.7 0.77
Currently living with a spouse, partner, or significant other 19.2 28.3 0.024
Income*† <0.001
 ≥$25,000 6.3 38.7
 $20,000–$24,999 11.1 28.2
 $15,000–$19,999 17.4 8.6
 $10,000–$14,999 31.2 16.0
 < $10,000 34.0 8.6
Medicaid* 53.6 21.3 <0.001
Prescription drug coverage* 72.5 73.8 0.77
Primary care physician 84.2 96.2 <0.001
Hypertension 70.7 57.1 0.003
Diabetes 26.3 14.7 0.003
Health status <0.001
 Poor 18.0 7.1
 Fair 44.7 20.1
 Good 25.6 39.1
 Very good 9.4 26.1
 Excellent 2.3 7.6
Health literacy, adequate 26.7 81.5 <0.001
Depression† <0.001
 None 62.0 82.6
 Mild 33.8 14.1
 Severe 4.1 3.3
Social support, mean (SD)* 3.70 (0.96) 4.30 (0.70) <0.001
*
Missing data noted for income (34 participants), Medicaid (19), prescription drug coverage (5), and social support (22).
†
Percentages may not total 100 due to rounding.
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Table II
Responses and crude (unadjusted) odds ratios for medication adherence questions.
Question
n/N (%) of Participants
Crude Odds Ratio (95%
CI)
African American (n =
266)
White (n = 184)
“How often do you run out of your medications before you
refill them?” Response: “None of the time.”*
198/263 (75.3) 165/183 (90.2) 3.01 (1.72–5.28)
“How often do you follow the physician’s instructions on how
to take your medications?” Response: “All of the time.”†
204/263 (77.6) 164/182(90.1) 2.64 (1.50–4.64)
“How often have you forgotten to take your medicine?”
Response: “None of the time.”†
133/263 (50.6) 87/182 (47.8) 0.90 (0.61–1.31)
*
Data missing for 4 participants.
†
Data missing for 5 participants.
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Table III
Multivariate logistic regression models for medication adherence questions.
Variable
Adjusted Odds Ratio (95% CI)




How to Take Medication
Forgetting to Take
Medication
Race, African American (vs white) 1.60 (0.74–3.42) 2.49 (1.07–5.80) 0.65 (0.37–1.16)
Age 1.01 (0.97–1.05) 0.96 (0.91–1.00) 1.00 (0.96–1.03)
Sex, male 0.62 (0.29–1.32) 0.97 (0.45–2.09) 0.86 (0.48–1.53)
Currently living with a spouse, partner, or
significant other; yes
1.07 (0.50–2.32) 0.66 (0.28–1.58) 1.03 (0.58–1.83)
Income, ≥$25,000 Reference Reference Reference
 $20,000–$24,999 0.86 (0.31–2.41) 3.25 (0.95–11.1) 0.45 (0.22–0.93)
 $15,000–$19,999 0.94 (0.31–2.91) 4.13 (1.10–15.5) 0.81 (0.35–1.88)
 $10,000–$14,999 0.91 (0.32–2.60) 1.68 (0.45–6.25) 0.39 (0.18–0.84)
 < $10,000 0.66 (0.21–2.14) 2.27 (0.58–8.98) 0.34 (0.14–0.83)
Medicaid, yes 0.74 (0.40–1.35) 0.70 (0.36–1.37) 1.11 (0.68–1.82)
Prescription drug coverage, yes 1.09 (0.58–2.05) 1.23 (0.60–2.53) 1.07 (0.65–1.75)
Primary care physician, yes 0.59 (0.27–1.29) 1.53 (0.59–3.94) 1.29 (0.64–2.62)
Hypertension, yes 0.89 (0.49–1.63) 0.38 (0.20–0.71) 1.20 (0.75–1.91)
Diabetes, yes 1.74 (0.91–3.30) 0.47 (0.20–1.09) 0.72 (0.42–1.25)
Health status, poor Reference Reference Reference
 Fair 0.90 (0.39–2.08) 0.73 (0.29–1.84) 1.14 (0.54–2.40)
 Good 0.64 (0.25–1.64) 0.44 (0.15–1.28) 1.18 (0.53–2.64)
 Very good 0.67 (0.22–2.09) 0.96 (0.30–3.14) 1.48 (0.60–3.64)
 Excellent 0.70 (0.12–3.97) 2.28 (0.47–11.1) 0.52 (0.14–1.94)
Health literacy, adequate 0.66 (0.33–1.33) 0.86 (0.41–1.84) 0.72 (0.41–1.26)
Depression, none Reference Reference Reference
 Mild 1.42 (0.72–2.81) 0.63 (0.28–1.42) 1.24 (0.70–2.21)
 Severe 3.22 (0.84–12.4) 1.62 (0.38–6.86) 3.35 (0.85–13.2)
Social support 0.89 (0.63–1.27) 0.51 (0.35–0.76) 0.60 (0.44–0.81)
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